Business and science: What you need to know about SynBio

Business and science: What you need to know a...

Up next

Founders: Moderna's Noubar Afeyan

Noubar Afeyan helped bring one of medicine's biggest breakthroughs to the world through Moderna's Covid-19 vaccine. In this episode, he explains why what looked like an overnight success was actually decades in the making.Presenter: Will Bain Producers: Barbara George and David C ...  Show more

Headspace: from mindfulness app to military partner

Headspace started life as a mindfulness app. Now it's partnering with the US Navy and investing in artificial intelligence for mental health support.The company's CEO Tom Pickett speaks to us about therapy, the increasing role of technology, and tackling burnout at scale.If you'd ...  Show more

Recommended Episodes

Turning Cells into Tiny Factories
What's Your Problem?

Reshma Shetty is co-founder and chief operations officer of Ginkgo Bioworks. Her problem: How do you turn cutting-edge science into a sustainable business?

Ginkgo is a synthetic biology company. The idea is to make industrial products -- fragrances, or food, or whatever ...

  Show more

The Science Behind Building a Profitable Business
Shopify Masters

You'll learn the rules of thumb from building a successful business from a serial entrepreneur. 

For more on Beast and  show notes: https://www.shopify.com/blog/beast-inventory-management?utm_campaign=shopifymasters&utm_medium=description&utm_source=podcast

<h3 ...  Show more

Business Plans and Science Projects
Motley Fool Hidden Gems Investing

Do you have a real relationship or just a non-binding letter of intent? (00:21) Nick Sciple and Mary Long discuss: - The S&P’s turnaround and inflation’s slow month-over-month decline. - A stock pop from a nuclear reactor company that doesn’t have a working nuclear reactor. - Pri ...  Show more

Leading with science: A deep dive on biotech
Center For Investment Excellence

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more